# CoQ10 and D-ribose in Patients With Diastolic Heart Failure

Study · id `cardio:ct-nct03133793` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03133793](<https://clinicaltrials.gov/study/NCT03133793>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03133793

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 216 participants.

## Technical summary

Registry record NCT03133793. Randomized; double masking; primary purpose treatment. Start 2018-02-05 (actual); primary completion 2021-03-12 (actual). Results posted on 2022-03-03.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 216 participants (enrolled count; ClinicalTrials.gov record NCT03133793, source copy `cardio:ctgov-nct03133793-2022-03-18`, retrieved 2026-10-26)
- Started: 2018-02-05 (actual) (ClinicalTrials.gov record NCT03133793, source copy `cardio:ctgov-nct03133793-2022-03-18`, retrieved 2026-10-26)
- Primary completion: 2021-03-12 (actual) (ClinicalTrials.gov record NCT03133793, source copy `cardio:ctgov-nct03133793-2022-03-18`, retrieved 2026-10-26)
- Completion: 2021-03-12 (actual) (ClinicalTrials.gov record NCT03133793, source copy `cardio:ctgov-nct03133793-2022-03-18`, retrieved 2026-10-26)
- Results first posted: 2022-03-03 (ClinicalTrials.gov record NCT03133793, source copy `cardio:ctgov-nct03133793-2022-03-18`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03133793, source copy `cardio:ctgov-nct03133793-2022-03-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03133793-2022-03-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: CoQ10 and D-ribose in Patients With Diastolic Heart Failure
- Condition: Heart Failure, Diastolic
- Intervention (Drug): CoQ10
- Intervention (Drug): D-Ribose Oral Powder
- Intervention (Other): Placebo pills
- Intervention (Other): Placebo powder
- Lead sponsor: University of Kansas Medical Center
- Lead sponsor class: OTHER
- Collaborator: National Institute on Aging (NIA)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart failure with mildly reduced or preserved ejection fraction (`cardio:hfpef`)
- Registry lists this organization as the lead sponsor: University of Kansas Medical Center (`cardio:org-university-of-kansas-medical-center`)
- Registry lists this organization as a collaborator: National Institute on Aging (`cardio:nia`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of Ubiquinol and/or D-ribose in Patients With Heart Failure With Preserved Ejection Fraction (`cardio:pubmed-35644694`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: d51b0de19a924722dcea81949a3e52e81033c5ac7621eaa25dff369387a09a10
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
